https://www.ndtvprofit.com/business/big-pharma-cos-set-to-return-to-double-digit-growth-this-fiscal-crisil?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Green shoots are already visible in the first quarter for 20 of these listed drug-makers, according to the rating agency.